KATHERINE HEFNER: Open Payments
NPI 1477651206 · CLYDE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 53 payments from 15 companies in 2025. Trend: 2023 $2,027 · 2024 $1,342 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $199 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $114 |
| E.R. Squibb & Sons, L.L.C. | 5 | $96 |
| Amgen Inc. | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $77 |
| Merck Sharp & Dohme LLC | 4 | $70 |
| Actelion Pharmaceuticals US, Inc. | 2 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $64 |
| Ascendis Pharma Endocrinology Inc | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
Products named: ELIQUIS, Kerendia, FARXIGA, VERQUVO, REPATHA, JARDIANCE, Yorvipath, LEQVIO.
Industry payments across NC — which companies pay providers there.
